Pakistan Medicines & Pharma IntelligenceMedicine data  •  Company portfolios  •  Price records
MedInfoBaseMedicines · Evidence · Intelligence
Home / Pharmaceutical company intelligence
Pharmaceutical company intelligence

Popular Chemical Works Pvt Ltd.,

Pharmaceutical manufacturer · Pakistan

Database-driven profile Portfolio, price and regulatory-source intelligence derived from MedInfoBase records.
ShareSend this page
Regulatory & corporate identity

Company profile

Not yet verified
Company type
Pharmaceutical manufacturer
DRAP-linked licence identifiersShown as recorded in linked source rows; not a claim of current validity.
DML 000076 27 linked products · source seen 9 Aug 2026 View source ↗
Location intelligence

Company location

Google Maps
Exact site not yet verified

MedInfoBase will not invent a factory or office location. The map appears after a sourced address, Place ID or verified embed URL is added.

Open in Google Maps ↗ The Google Maps search link uses the company name and available city/country context; it is not presented as a verified premises pin.
Intelligence snapshot

Portfolio at a glance

Not sales data · current MedInfoBase database view
Rx27product presentations
G13generic molecules
DF5dosage-form groups
TA5therapeutic areas
PKR27current price records
REG25registration numbers
Data coverage

How complete is this profile?

Current price coverage100%
products with a current official price
Source-linked coverage100%
products linked back to a source record
Unit-price parse coverage100%
priced packs safely normalized per unit
Comparable-market coverage100%
products with at least one like-for-like comparator
Therapeutic classification100%
products assigned to a broad therapeutic area
Visual intelligence

Downloadable company intelligence charts

Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.

Shareable intelligence

Therapeutic Portfolio Mix

Shows where the company portfolio is concentrated across broad therapeutic areas.

Therapeutic Portfolio MixPopular Chemical Works Pvt Ltd.,Share of current product presentations by broad therapeutic areaMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/popular-chemical-works-pvt-ltdGenerated 9 Aug 2026Anti-infectives15 · 56%CNS & mental health6 · 22%Endocrine & metabolic3 · 11%Gastrointestinal & hepatology2 · 7%Pain & musculoskeletal1 · 4%Percentages are based on current product presentations in the MedInfoBase company portfolio.

Portfolio distribution, not sales or market-share data.

Shareable intelligence

Dosage Form Portfolio

Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.

Dosage Form PortfolioPopular Chemical Works Pvt Ltd.,Distribution of current product presentations by normalized dosage formMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/popular-chemical-works-pvt-ltdGenerated 9 Aug 202627presentationsTablet15 · 56%Suspension6 · 22%Capsule4 · 15%Drops1 · 4%Syrup1 · 4%Dosage-form wording is normalized for intelligence display; original source wording remains preserved in product records.

Counts are product presentations, not production or sales volumes.

Shareable intelligence

Equivalent-Market Price Position

Shows whether safely comparable products are below, near or above the market median unit price.

Equivalent-Market Price PositionPopular Chemical Works Pvt Ltd.,Current company products compared with like-for-like equivalent medicines using normalized unit pricesMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/popular-chemical-works-pvt-ltdGenerated 9 Aug 202627comparable productsBelow market median10 · 37%Near market median12 · 44%Above market median5 · 19%Company median price position-4.3%Lowest-price equivalents1Method: same generic + stated strength + dosage form + compatible unit basis; pack prices normalized per unit.

This is price-position intelligence, not sales, demand or market-share data.

Shareable intelligence

Closest Portfolio Competitors

Highlights other manufacturers with the greatest generic overlap with this company portfolio.

Closest Portfolio CompetitorsPopular Chemical Works Pvt Ltd.,Companies with the largest number of shared generic medicines in the MedInfoBase databaseMedInfoBase • medinfobase.comSource profile: medinfobase.com/company/popular-chemical-works-pvt-ltdGenerated 9 Aug 2026Mediate Pharmaceutical Pvt Ltd11 shared85% overlapWerrick Pharmaceuticals10 shared77% overlapAGP Limited9 shared69% overlapStandpharm Pakistan Pvt Ltd9 shared69% overlapPharmedic Laboratories (Pvt.) Ltd L…9 shared69% overlapPulse Pharmaceuticals (Pvt.) Ltd.9 shared69% overlapPortfolio overlap measures shared generics only; it is not a measure of market share, affiliation or sales competition.

Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.

Portfolio intelligence

Therapeutic areas

Broad portfolio view

High-level clinical areas represented by this company’s current MedInfoBase portfolio.

Anti-infectives15 products · 56%
CNS & mental health6 products · 22%
Endocrine & metabolic3 products · 11%
Gastrointestinal & hepatology2 products · 7%
Pain & musculoskeletal1 products · 4%
Pharmacological detail

Drug classes

More specific view

More specific classes derived from the canonical generic and preserved curated classifications.

Penicillin antibacterials7 products · 26%
Antipsychotics4 products · 15%
Antidiabetic medicines3 products · 11%
Third-generation cephalosporins3 products · 11%
Benzodiazepines / sedatives2 products · 7%
Nitroimidazole anti-infectives2 products · 7%
Fluoroquinolone antibacterials2 products · 7%
Analgesics / NSAIDs1 products · 4%
Formulation footprint

Dosage forms

Tablet15 products
Suspension6 products
Capsule4 products
Drops1 products
Syrup1 products
How MedInfoBase classifies the portfolio

MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.

Portfolio leaders

Deepest brand families

Ranked by registered presentations · not sales
#1 MoxiliumAmoxicillin 6presentations 125 mg/1.25 mL, 125 mg/5 mL, 250 mg/5 mL, 500 mg · Drops, Suspension, Capsule #2 IsripRisperidone 4presentations 1 mg, 2 mg, 3 mg, 4 mg · Tablet #3 BiguanilMetformin 2presentations 250 mg, 500 mg · Tablet #4 MetronidazoleMetronidazole (Benzoate) 2presentations 200 mg, 400 mg · Tablet #5 SaveloxLevofloxacin 2presentations 250 mg, 500 mg · Tablet #6 SupracefCefixime 2presentations 100 mg/5 mL, 400 mg · Suspension, Capsule
Price intelligence

Unit-price positioning vs equivalent products

Same generic + strength + form + unit basis
Below market median1037% of comparable products
Near market median12within ±5% of median
Above market median519% of comparable products
Lowest-price equivalents1ties included
Company median price position -4.3% relative to the median unit price of like-for-like equivalent products.
Most competitively positioned examplesProducts with at least 3 market comparators
Diazepam 5 mgDiazepam · Tablet · 1000's PKR 0.48/tablet-64.7% vs market median Savelox 500 mgLevofloxacin · Tablet · 1x10's PKR 37.82/tablet-51.9% vs market median Savelox 250 mgLevofloxacin · Tablet · 1x10's PKR 24.33/tablet-48.8% vs market median Isrip 3 mgRisperidone · Tablet · 1x10's PKR 37.63/tablet-34.9% vs market median Isrip 4 mgRisperidone · Tablet · 1x10's PKR 50.18/tablet-30.5% vs market median
How MedInfoBase calculates price position

Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.

Competitive landscape

Portfolio overlap

Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.

Mediate Pharmaceutical Pvt Ltd239 products · 90 generics 11shared generics Werrick Pharmaceuticals249 products · 82 generics 10shared generics AGP Limited220 products · 68 generics 9shared generics Standpharm Pakistan Pvt Ltd145 products · 49 generics 9shared generics Pharmedic Laboratories (Pvt.) Ltd Lahore122 products · 70 generics 9shared generics Pulse Pharmaceuticals (Pvt.) Ltd.115 products · 48 generics 9shared generics
Regulatory & price activity

Observed database signals

Registration numbers25
Price-history records29
Products with price history1
Source records with multiple versions0
Latest MedInfoBase verification9 Aug 2026
Latest effective price date1 Jul 2025
Latest source observation9 Aug 2026

These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.

Sponsored company campaign area · advertising must be clearly disclosed
Complete company portfolio

Products and presentations

27 results
Reset
BrandGenericStrengthFormPackRegistrationOfficial priceUnit priceMarket position
Avor Lorazepam 2 mg Tablet 10x10's 007853 PKR 368.94 PKR 3.69/tablet 138% above median
Biguanil Metformin 500 mg Tablet 5x10's 005310 PKR 139.63 PKR 2.79/tablet Near median
Biguanil Metformin 250 mg Tablet 10x10's 003718 PKR 193.09 PKR 1.93/tablet 17% below median
Codamin-P Paracetamol 15 mg Tablet 1x50's 028729 PKR 297.36 PKR 5.95/tablet Near median
Diazepam Diazepam 5 mg Tablet 1000's 002984 PKR 475.99 PKR 0.48/tablet 65% below median
Gliben Glibenclamide 5 mg Tablet 5x10's 012648 PKR 93.09 PKR 1.86/tablet 23% below median
Isrip Risperidone 1 mg Tablet 1x10's 035294 PKR 167.24 PKR 16.72/tablet 26% below median
Isrip Risperidone 2 mg Tablet 1x10's 035295 PKR 250.89 PKR 25.09/tablet 30% below median
Isrip Risperidone 3 mg Tablet 1x10's 035296 PKR 376.32 PKR 37.63/tablet 35% below median
Isrip Risperidone 4 mg Tablet 1x10's 035297 PKR 501.76 PKR 50.18/tablet 30% below median
Maltem Plus Artemether 20 mg Tablet 1x16's 085180 PKR 608.20 PKR 38.01/tablet Near median
Metronidazole Metronidazole (Benzoate) 200 mg Tablet 100's 008909 PKR 249.79 PKR 2.50/tablet 55% above median
Metronidazole Metronidazole (Benzoate) 400 mg Tablet 100's 081274 PKR 361.02 PKR 3.61/tablet 21% above median
Moxilium Amoxicillin 125 mg/5 mL Suspension 45ml 006783 PKR 65.39 PKR 1.45/mL Near median
Moxilium Amoxicillin 125 mg/5 mL Suspension 60ml 006783 PKR 87.18 PKR 1.45/mL Near median
Moxilium Amoxicillin 125 mg/5 mL Suspension 90ml 006783 PKR 130.22 PKR 1.45/mL Near median
Moxilium Amoxicillin 250 mg/5 mL Suspension 60ml 012649 PKR 128.02 PKR 2.13/mL Near median
Moxilium Amoxicillin 500 mg Capsule 20's 088908 PKR 388.47 PKR 19.42/capsule Near median
Moxilium Amoxicillin 125 mg/1.25 mL Oral drops 10ml 006782 PKR 44.88 PKR 4.49/mL 36% above median
Moxilium Each1.25ml Amoxicillin 250 mg Capsule 20's 006784 PKR 215.20 PKR 10.76/capsule Near median
MedInfoBase company-intelligence methodology

This page is generated from MedInfoBase medicine, generic, company, price and DRAP-source records. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.

Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.